Accounting for Variability in Sample Size Estimation with Applications to Nonadherence and Estimation of Variance and Effect Size
- 12 December 2006
- journal article
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 63 (2), 465-474
- https://doi.org/10.1111/j.1541-0420.2006.00703.x
Abstract
We consider sample size calculations for testing differences in means between two samples and allowing for different variances in the two groups. Typically, the power functions depend on the sample size and a set of parameters assumed known, and the sample size needed to obtain a prespecified power is calculated. Here, we account for two sources of variability: we allow the sample size in the power function to be a stochastic variable, and we consider estimating the parameters from preliminary data. An example of the first source of variability is nonadherence (noncompliance). We assume that the proportion of subjects who will adhere to their treatment regimen is not known before the study, but that the proportion is a stochastic variable with a known distribution. Under this assumption, we develop simple closed form sample size calculations based on asymptotic normality. The second source of variability is in parameter estimates that are estimated from prior data. For example, we account for variability in estimating the variance of the normal response from existing data which are assumed to have the same variance as the study for which we are calculating the sample size. We show that we can account for the variability of the variance estimate by simply using a slightly larger nominal power in the usual sample size calculation, which we call the calibrated power. We show that the calculation of the calibrated power depends only on the sample size of the existing data, and we give a table of calibrated power by sample size. Further, we consider the calculation of the sample size in the rarer situation where we account for the variability in estimating the standardized effect size from some existing data. This latter situation, as well as several of the previous ones, is motivated by sample size calculations for a Phase II trial of a malaria vaccine candidate.Keywords
This publication has 13 references indexed in Scilit:
- Sample Size Determination for Clinical TrialsPublished by Wiley ,2005
- Life of the mind: The interface of psychopharmaceuticals, domestic economies, and social abandonmentAmerican Ethnologist, 2004
- Bayesian Statistics and the Efficiency and Ethics of Clinical TrialsStatistical Science, 2004
- A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trialsStatistics in Medicine, 2004
- Sample Size Calculations for Randomized Controlled TrialsEpidemiologic Reviews, 2002
- Statistical Considerations in the Intent-to-Treat PrincipleControlled Clinical Trials, 2000
- Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing ModelsAmerican Journal of Epidemiology, 1996
- R. A. Fisher's Fiducial Argument and Bayes' TheoremStatistical Science, 1992
- Negative binomial and mixed Poisson regressionThe Canadian Journal of Statistics / La Revue Canadienne de Statistique, 1987
- Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort StudiesInternational Journal of Epidemiology, 1984